Skip to content

Evaluation of pulmonary function conditions pre-radiotherapy in breast cancer treatment.

A single group study on early detection of functional pulmonary loss before radiotherapy on breast cancer patients.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000122954
Enrollment
36
Registered
2011-02-03
Start date
2008-04-22
Completion date
2009-06-23
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study was to transversally detect, by means of routinely used physiotherapeutic instruments and a functional test, alterations in pulmonary functions due to the systemic treatments pre-radiotherapy in breast cancer treatment. Women submitted to breast cancer systemic treatments show a decrease in pulmonary function, which impairs their respiratory conditions pre-radiotherapy.

Interventions

The patients’ pulmonary function was evaluated immediately before they were submitted to radiotherapy, using clinical instruments, such as incentive spirometers, manuvacuometer, peak flow, and six minute walk test. Each patient was assessed once only and the duration of the evaluation was thirty minutes.

Sponsors

Renata de Carvalho Schettino
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Documented breast cancer diagnosis, operated, with radiotherapy proposition as an adjuvant treatment, after chemotherapy and/or hormone therapy neoadjuvant or adjuvant, no past or present clinical evidence of benign or malign pulmonary disease based on oncological follow up and previous history and cognitive capacity to understand simple commands and to execute tasks during testing.

Exclusion criteria

Women who were submitted to radiotherapy concomitant to chemotherapy were excluded from the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026